Radiopharmaceuticals represent one of the fastest-growing and most innovative therapeutic classes in oncology. This role is critical to ensuring that patients who stand to benefit from targeted therapies can access them swiftly, affordably, and equitably — while also navigating the complex and often unprecedented access challenges unique to this modality. The RayzeBio Market Access Strategy & Go-to-Market Lead is a strategic and cross-functional role responsible for developing and executing market access strategies for RayzeBio. This individual will work at the intersection of oncology, nuclear medicine, health economics, and payer strategy to ensure timely and broad patient access to innovative therapies. The RayzeBio Market Access Strategy & Go-to-Market Lead will serve as the Market Access strategic partner to BMS functional teams and capabilities, shaping organization strategic considerations in anticipation of approval and commercialization. The successful candidate will play a critical role in advancing RayzeBio’s go-to-market strategies by leveraging diverse industry experience and deep Market Access functional expertise. With a primary focus on the US market, while maintaining a global perspective, the successful candidate will shape and deliver essential market access strategies, optimize operational processes, and ensure seamless patient and provider experiences.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Number of Employees
5,001-10,000 employees